DBV Technologies (DBVT) Invested Capital (2015 - 2020)
DBV Technologies (DBVT) posted Invested Capital of $644354.2 for Q2 2020, down 99.14% sequentially from $75.0 million in Q4 2019, and little changed YoY from $642721.6 in Q3 2019.
Analysis
DBV Technologies (DBVT) Invested Capital (2015 - 2020) Analysis & Trends
DBV Technologies has reported Invested Capital for 6 years, with the latest figure at $644354.2 in Q2 2020.
- Quarterly Invested Capital changed 0.25% year-over-year to $644354.2 in Q2 2020, while the trailing twelve-month figure through Mar 2021 was $644354.2 (down 99.5% YoY) and the FY2019 annual result came in at $75.0 million, up 37.96% from the prior year.
- Invested Capital fell to $644354.2 in Q2 2020 per DBVT's latest filing, from $75.0 million in the prior quarter.
- Over five years, Invested Capital peaked at $75.0 million in Q4 2019 and troughed at $638117.0 in Q4 2016.
- A 5-year average of $30.9 million and a median of $27.2 million in 2020 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2017 and 2020: Invested Capital surged 8334.44% in 2017, then advanced 0.25% in 2020.
- Over 5 years, Invested Capital stood at $638117.0 in 2016, then soared by 8334.44% to $53.8 million in 2017, then rose by 1.06% to $54.4 million in 2018, then surged by 37.96% to $75.0 million in 2019, then slumped by 99.14% to $644354.2 in 2020.
- According to Business Quant data, Invested Capital over the past three periods registered $644354.2, $75.0 million, and $642721.6 for Q2 2020, Q4 2019, and Q2 2019 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.30 Bn |
| 10 | DBV Technologies | 5.88 Bn | 5.70 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | 252.54 Mn |
| Dec 31, 2019 | 193.98 Mn |
| Jun 30, 2019 | 131.84 Mn |
| Dec 31, 2018 | 139.89 Mn |
| Dec 31, 2017 | 155.12 Mn |
| Dec 31, 2016 | 266.58 Mn |
| Dec 31, 2015 | 358.18 Mn |